Oxford Nanopore Technologies PLC (LSE:ONT) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Heather Preston Other companies: Aligos Therapeutics, Inc. (Director · Since at least Aug 7, 2024); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Fusion Pharmaceuticals Inc (Director · Jun 25, 2020 – Jun 14, 2023 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Jun 24, 2021 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jun 19, 2019 · Past); Albireo Pharma Inc (Director · Nov 3, 2016 – Jan 23, 2017 · Past); Otonomy Inc (Director · Aug 12, 2014 – Jun 11, 2019 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 22, 2019 · Past) | Non Executive Director · Since at least May 1, 2026 |
| Adrian Hennah Other companies: Unilever PLC (Non-Executive Director · Since at least May 13, 2026) | Non-executive Director · Since at least Oct 12, 2026 |
| Francis Van Parys Other companies: Danaher Corporation (Chief Executive Officer · Dec 8, 2025 – Nov 5, 2026 · Past) | Chief Executive Officer · Since at least Oct 20, 2026 |
| John O'Higgins Other companies: Technip Energies NV (Independent Director, Chair of the Board and Chair of the Nomination and Governance Committee · Since at least Apr 30, 2026) | Non-executive Director · Since at least May 1, 2026 |
| Alvaro Correia | VP, Global Supply Chain · Since at least Nov 4, 2026 |
| Andrew Watson | Chief Information Officer · Since at least Aug 19, 2026 |
| Ant Jones | VP, Engineering · Since at least Nov 4, 2026 |
| Chris Hannan | VP, Quality Assurance and Regulatory Affairs · Since at least Nov 4, 2026 |
| Conor McKechnie | Chief Marketing and Communications Officer · Since at least Aug 25, 2026 |
| Daniel Mahony | Non Executive Director · Since at least May 1, 2026 |
| Davide Manissero | Chief Medical Officer · Since at least Aug 19, 2026 |
| David Miller | Chief Development and Product Officer · Since at least Aug 25, 2026 |
| David Stoddart | VP, Sample Technology · Since at least Nov 4, 2026 |
| Duncan Tatton-Brown | Chairman of the Board · Since at least May 1, 2026 |
| Gretchen Weightman | VP & GM, APAC · Since at least Mar 17, 2026 |
| Hannah Coote | Vice President, Associate General Counsel · Since at least Aug 19, 2026 |
| Jayne Wallace | VP, Nanopore Research and Protein Sequencing · Since at least Nov 4, 2026 |
| Jeremy Bryar | VP, Manufacturing · Since at least Nov 4, 2026 |
| Jordan Herman | SVP, General Counsel · Since at least Nov 5, 2026 |
| Kate Priestman | Non Executive Director · Since at least May 1, 2026 |
| Kristen Stoops | VP, Strategic Marketing and Business Development · Since at least Nov 4, 2026 |
| Lakmal Jayasinghe | Chief Scientific Officer · Since at least Mar 4, 2025 |
| Martyn Andrews | VP, Intellectual Property · Since at least Nov 4, 2026 |
| Nick Keher | Chief Financial Officer · Since at least Oct 14, 2026 |
| Nirmala Santiapillai | VP, Commercial Operations · Since at least Nov 4, 2026 |
| Oliver Hartwell | VP, Strategic Planning · Since at least Nov 4, 2026 |
| Phil Watkins | VP, Finance · Since at least Nov 4, 2026 |
| Rhodri Davies | VP, Operations · Since at least Nov 4, 2026 |
| Sarah Fortune | Non Executive Director · Since at least May 1, 2026 |
| Sarah Woods | VP, Global IT · Since at least Nov 4, 2026 |
| Sebastian Kronmueller | Chief Business Development Officer · Since at least Oct 20, 2026 |
| Sissel Juul | VP, Applications · Since at least Nov 4, 2026 |
| Stephanie Abernathy | VP, Commercial · Since at least Nov 4, 2026 |
| Thomas Bray | VP, Business Development · Since at least Nov 4, 2026 |
| Tina St. Leger | Chief People Officer · Since at least Aug 19, 2026 |
| Tonya McSherry | VP Commercial, EMEAI · Since at least Nov 4, 2026 |